Achieving Data Quality and Integrity in Clinical Trials Involving High Consequence Pathogens — Clinical CourseFDA-UTMB Collaborative Education Program

Course Dates: July 30 – August 1, 2024

Course Format

In-person (at UNMC) or Virtual

Course Fees

There are no fees associated with course attendance; however, seating for in-person attendance is limited and interested participants will be placed on a wait-list once seats are filled. Travel expenses and meals are incurred at the individual’s expense. Refer to hotel information below.

Course Pre-registration

Whether requesting to attend the course in-person or virtually, course registration is a 3-step process. The first step is to pre-register for the course to indicate your interest in attending. After completing the pre-registration form, you will receive an email with a second link where you will complete a short survey that gathers information on your knowledge and experience. Notification of course admittance will follow, and step 3 is your confirmation of attendance.

Pre-registration is Open Now!

Click Here to Pre-Register for IN-PERSON attendance

IN-PERSON Pre-Registration closes June 30, 2024

Click Here to Pre-Register for VIRTUAL attendance

VIRTUAL Pre-Registration closes July 12, 2024

Course Description

This three day (two days for virtual attendees) interactive course allows participants to enhance knowledge and integrate practical considerations for the planning and operation of clinical research protocols involving medical countermeasures for high consequence pathogens. Course participants acquire knowledge through innovative learning platforms and problem-based scenarios that help identify and mitigate barriers to data quality and integrity in domestic and international barrier nursing environments.

Target Audience

Physicians, Scientists, Principal Investigators, Physician Assistants, Nurse Practitioners, Nurses, Pharmacists, Clinical Laboratorians, Clinical Research Staff, Clinical Monitors, Regulators, Policymakers, Regulatory Reviewers, IRB Professionals, Biosafety Professionals, and Sponsors that have interest in clinical trials

2024 Planned Course TopicsDays and Titles are Subject to Change

2024 Planned Course Topics - Clinical Course

  • Day 1
    • Clinical Research at the Ebola Virus Disease Bedside
    • Challenges of Emerging Infectious Disease Clinical Studies in an Epidemic Setting
    • The Varied Roles of Human and Animal Efficacy Data in MCM Development
    • Overview of GCP
    • Writing Effective SOPs
    • Operationalizing a Protocol
    • Sample Collection
    • Tales from the Diamond Princess (COVID Pandemic)
    • International and Domestic Cultural and Language Barriers
  • Day 2
    • The One Health Initiative in MCM Development
    • Protocol Driven Data Collection vs. Clinical Data
    • The Impact of Good Documentation Practices
    • Study Monitoring
    • Deviations vs. Serious Deviations
    • Participation Barriers
    • Roles and Responsibilities of the IRB
    • Regulatory Requirements
  • Day 3 (In-person Attendees Only)
    • Workplace Risk Assessments
    • Donning and Doffing of high level PPE
    • Waste Management
    • Simulation Exercises in Mock Barrier Nursing Environment

Course Schedule

Course organizers are in the process of finalizing the 2024 course agenda. As a reference, you may wish to view the 2023 agenda. The 2023 course was held in a virtual format only; therefore, the 2023 agenda shows Days 1 and 2. The 2024 course is planned to be held in-person (3 days) and virtually (2 days). The tentative 2024 course schedule is listed below.

In-person attendees will be required to check-in between 7:45 am – 8:00 am CDT on Tuesday, July 30, 2024.

July 30 – 31, 2024 (In-person and virtual attendees)
8:00 am – 5:00 pm CDT

August 1, 2024 (In-person attendees only)
7:30 am – 1:30 pm CDT

Course Faculty

The Clinical Course faculty include clinicians, nurses, biosafety officers, government leaders, and federal agency representatives with field experience from the US Department of Health and Human Services Food and Drug Administration (FDA), National Institutes of Health (NIH), Biomedical Advanced Research and Development Authority (BARDA), United States Department of Agriculture (USDA), University of Nebraska Medical Center (UNMC), University of Texas Medical Branch (UTMB), and Emory University.

Prerequisite Knowledge

A basic understanding of the Good Clinical Practice (GCP) is highly recommended. To meet this need, access to a free online course will be provided to course attendees.

  • Basic GCP — This interactive modular online course is designed to provide an overview of Good Clinical Practice (GCP). Content summarizes the basic elements of GCP. For the novice, this online course provides a good introduction of the topic; for those with prior knowledge of GCP, this course provides a refresher of the ethical and quality standards described in GCP. This course focuses on GCP regarding the conduct of clinical research studies involving the investigation of drugs and biologics.

Course Certification, Learning Objectives, and Learning Outcomes

Continuing Education: This course is submitted for Continuing Education credits for nurses and quality assurance professionals. Details will be posted closer to course dates.

Course Learning Objectives

  1. Formulate solutions to regulatory, operational, and cultural challenges for the conduct of clinical trials of medical countermeasures for high consequence pathogens.
  2. Identify and mitigate risks to data quality and integrity.
  3. Resolve complexities of performing clinical trials in biocontainment / barrier nursing environment under GCP.
  4. Experience the conduct of clinical research tasks in a mock biocontainment / barrier nursing environment while wearing high level PPE (in-person attendees only).

Course Learning Outcomes

  1. Utilize best practices for the design and implementation of research clinical trials during an outbreak involving high consequence pathogens.
  2. Recognize and prevent potential risks to data quality and integrity.
  3. Apply the GCP principles to research clinical studies of medical countermeasures for high consequence pathogens.
  4. Mitigate data collection challenges in a biocontainment / barrier environment.

Course Location

The course will take place at the University of Nebraska Medical Center (UNMC)  located in Omaha, Nebraska. The in-person activities on Day 3 will take place at the Training, Simulation, and Quarantine Center located in the Global Center for Health Security at the Davis Global Center.  

UNMC Global Center for Health Security
985551 Nebraska Medical Center
Omaha, Nebraska 68198 - 5551

The Training, Simulation, and Quarantine Center (TSQC) provides a 6-bed high-fidelity simulated biocontainment unit training center, emergency operations center, laboratory, multipurpose room for incident management and skills training, and is the only federally-funded, 20-bed National Quarantine Unit (NQU) in the United States. To learn more about the TSQC and NQU, click here.

Course Hotels — Places to stay while in Omaha

Click the link above  to view options of places to stay while in Omaha

Travel to and within Omaha

Omaha is accessible by air via Eppley Airfield (OMA). Visit for more information. Course attendees may want to extend their stay to enjoy the city!

Airport Information

Visit Omaha 

Henry Doorly Zoo and Aquarium

Bob Kerrey Pedestrian Bridge

Joslyn Castle & Gardens

Bemis Center for Contemporary Arts

The Old Market

Course/Event Software Application

Course organizers utilize the WHOVA event management software for hosting the course. A link to the course site will be provided to registered course attendees (both in-person and virtual attendees) approximately 1 week prior to the course start date. Use of the Whova application has been approved for FDA employees.

Frequently Asked Questions

Frequently Asked Questions (FAQs) Clinical Course

  • Pre-registration and Course Admittance

    Q1: Are there any fees associated with attending this course?

    A1: No! The course is funded by an educational grant through the U.S. Department of Health and Human Services Food and Drug Administration (FDA). In-person attendees will be responsible for expenses related to travel.

    Q2. What is the difference between pre-registration and course admittance?

    A2. Admittance to the course, whether attending in-person or virtually, is a 3-step process. While course organizers try to accommodate all requests, the total number of attendees is limited; therefore, admittance is based on availability. After completion of Steps 1 and 2, you will be notified if you have been admitted to the course. Please allow up to 30 days for the admissions process. Step 3 is your acceptance to the course invitation. Upon admission, you will receive additional information.

    Q3. I submitted my pre-registration information, but I have not yet heard whether I have been accepted into the course. What should I do?

    A3: First, please check your Spam folder to be sure that the email has not been blocked by a firewall. If you have not received notification after 30 days from completing Steps 1 and 2 of the pre-registration process, please send an inquiry to If you need to inquire on the status of your application in order to make travel reservations, you may also send an email to

  • Registered Attendees

    Q4: I am attending the course and have a colleague who will benefit from this knowledge. Can I share the meeting link with them?

    A4: We are happy to hear that the content is relevant; however, we must track all attendees. If your colleague would like to have access, please email a request to and someone will contact them directly.

    Q5: I am attending the course in-person. Is it possible to attend some lectures in-person and some virtually?

    A5: As there are a smaller number of individuals admitted for in-person attendance, in-person attendees are kindly reminded that someone else may be on a waiting list to be admitted. If there are unusual circumstances that require flexibility, please email your request to and course organizers will do their best to accommodate.

    Q6: I registered and was admitted to the course to attend in-person; however, I am now unable to attend in-person. What should I do?

    A6: Please send an email to as soon as possible. Course organizers can switch you from in-person attendance to virtual if you are still available to attend. Additionally, we can release your in-person seat to someone on the waiting list.

    Q7: I am attending the course virtually. Will I be able to submit questions to the presenters?

    A7: Yes! There will be a mechanism for submitting your questions. Instructions will be shared on the first day of the course.

    Q8: Will a certificate of completion be provided?

    A8: Yes, a certificate will be provided for those who attended the course in its entirety. We closely monitor online attendance for this purpose. For attendees seeking full or partial Continuing Education (CE) credits, instructions will be provided during and after the course. For virtual attendees, please assure you are consistently using the same name (first and last) and email for registration and course participation. If you experience an emergency that impacts your ability to participate fully, please email the course organizers at

    Q9: If I am unable to attend the entire course (in-person or virtual), will I be able to get a course certificate?

    A9: Please email the course organizers at and someone will contact you. If you will miss the majority of the course, you can be placed on a priority list for the 2025 course. If you will only miss a few sessions, we can provide instructions for claiming partial CE credits.

    Q10: I am registered to attend the course virtually; however, can I attend the mock exercises on Day 3?

    A10: These activities are reserved for in-person attendees. You can make a special request by emailing; however, please note that capacity is limited. Please make this request as early as possible.

    Q11: I will need a VISA to enter the US to take this course. Will you provide any sponsorship?

    A11: You may use your course invitation and the meeting website to help support your request. If you require any further written documentation, please email your request to Course organizers will try to accommodate by providing additional information as needed; however, we are unable to contact the respective Consulate directly. Please note that no financial assistance is available to offset travel expenses.

    Q12: Will Continuing Education credit be available for attendees?

    A12: Yes. Course organizers submit applications to certify the course for Continuing Nursing Education (CNE) and Registered Quality Assurance Professionals (RQAP). Once the course is approved, the accreditation information will be posted on the course website and Whova (course management application).  Instructions on how to claim credit will be provided at a later date.

    Q13: I am registered to attend the course, when can I expect to receive additional course information?

    A13: All registered attendees will receive an email approximately one week prior to the course start date that will contain additional information. If you do not receive information, check this website for general announcements or email

    Q14: Will I need to download any applications prior to attendance?

    A14: The course will be administered through the WHOVA event management platform. Instructions will be provided on how to access the course. UTMB has received authorization by FDA IT for use by FDA employees. For virtual attendees, lectures will be provided in Whova. Whova will have embedded streaming links through Zoom. Please ensure you can access Zoom. IF YOU ARE NOT ABLE TO DOWNLOAD THE WHOVA APPLICATION, please notify Katherine Rosen at  

    Q15: I did not indicate during course pre-registration that I wanted to take the online GCP course, but I would now like to take the course. What steps should I take?

    A15: Please email your first and last name along with your email address to and indicate that you would like to take the Basic GCP course. Course organizers will assure you are given access.

    Q16: I indicated my interest in taking the online GCP course. When will I have access to the course and how long will I have access?

    A16: You will receive an email from with access information. Access will be granted for approximately six weeks starting 1-2 weeks prior to the course start date.

    Q17: Will the presentation slides be made available to attendees?

    A17: Presentations will be provided after the course for sessions where faculty provided consent to release. Some information may be redacted.

    Q18: Will sessions be recorded and available for attendees?

    A18: No, sessions will not be recorded for the purpose of viewing by course attendees. Some sessions may be recorded to aid in future course development.

    Q19: I am an in-person attendee and am planning to sign-in each day using the WHOVA App. Do I also need to physically sign-in each day?

    A19: Yes, please physically sign-in as you arrive each day.

  • Logistics

    Q20: Will there be parking on campus?

    A20: In-person attendees will receive parking information in a Logistics email that will be sent approximately one week prior to the start of the course.

    Q21: Will lunch be provided?

    A21: No, lunch will be on your own. Information will be provided in a Logistics email that will be sent approximately one week prior to the start of the course.

    Q22: I need to travel home on Thursday. Will the course end early to allow time to travel to the airport?

    A22: Yes, the course will end around 3:15 pm on Thursday, August 1, 2024. This will allow ample time to commute to the airport. Eppley Airfield (OMA) is approximately 6 miles from the UNMC campus.

  • Further Inquiries

    If you do not find an answer to your question, please send your inquiry to Please include your name, email address, and state this is a question related to the UTMB/FDA Clinical Course.

Past Courses

Past Clincal Courses

  • Course History by Year


    October 4-6
    Live, Virtual


    July 11-13
    University of Nebraska Medical Center – Global Center for Health Security 
    Omaha, NE, USA


    August 2-4, 2021
    Live, Virtual


    October 26-28
    Live, Virtual

    2019 – Pilot Course

    April 8-10, 2019
    National Institutes of Health (NIH)
    Bethesda, MD, USA


A great course! Many thanks to the organizers and the presenters for taking time to prepare and present their knowledge and experience!
– 2023 Attendee

This course is very beneficial for bridging a gap in this field.
– 2023 Attendee

As someone interested in BSL3-4 research, I found the hands-on training equally valuable. Perhaps more importantly, I was able to diversify my network and make the acquaintance of a number of high profile clinicians.
– 2022 Attendee

This course was very interesting. I learned some things that I was not aware of and enjoyed the presentations.
– 2022 Attendee

Great work! It was evident the preparation made by all was top notch and the delivery was outstanding!
– 2021 Attendee

This was a great course. I really enjoyed meeting colleagues and working together toward a common goal. The level of expertise in the room was immense and we all learned from each other to a great extent.
– 2019 (pilot course) Attendee

Highlighted Speakers

Information coming soon!

Omaha, Nebraska Highlights

Need More Information?

Send an email with your question to